| Analysis | Metabolite Name | Measured Value | Units | subject type |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | CITRAMALATE (CAS# 2306-22-1); (M-H)- | 3878 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | CITRAMALATE (CAS# 2306-22-1); (M-H)- | 16010 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | CITRAMALATE (CAS# 2306-22-1); (M-H)- | 85601 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | CITRAMALATE (CAS# 2306-22-1); (M-H)- | 104564 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | CITRAMALATE (CAS# 2306-22-1); (M-H)- | Peak area | Healthy control | |
| Reversed phase NEGATIVE ION MODE | CITRAMALATE (CAS# 2306-22-1); (M-H)- | Peak area | Mild disease | |
| Reversed phase NEGATIVE ION MODE | CITRAMALATE (CAS# 2306-22-1); (M-H)- | Peak area | Severe disease |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|